ABSTRACT. The effects of fortified human milk feedings on the urinary excretion of lactoferrin, lysozyme, secretory component, IgA, and secretory IgA antibodies to Escheuichia coli 0 antigens were investigated in very low birth wt infants. Infants were maintained on either a human milk or a cow's milk preparation. The amounts of each immune factor that were ingested and excreted were quantified during balance studies conducted at 2.5 and 5 wk of age. Serum levels of these immune factors were similar in both feeding groups. The urinary excretion of all factors except lysozyme was 7-to 150-fold greater in infants fed human milk than in those fed cow's milk formula. IgA was the only factor for which the amount of the factor excreted correlated with the amount ingested. Fragments as well a s whole molecules of lactoferrin were found in the urine of the infants fed human milk, but the molecular sizes of the excreted proteins exceeded those normally filtered by the kidneys. Therefore, the genesis of the enhanced levels of host defense factors in the urine of infants fed human milk is not clear. Gastrointestinal absorption and subsequent renal excretion a s well as enhanced production of immune factors in the infant's urinary tract are possible explanations. (Pediatu Res 25:184-188, 1989) Abbreviations SIgA, secretory IgA SC, secretory component VLBW, very low birth weight infants FHM, fortified human milk CMF, cow's milk formula ELISA, enzyme-linked immunosorbent assay
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The concept that human milk protects the recipient infant is supported by the demonstration of reduced infectious morbidity among breast-fed compared to artificially fed infants and by the presence of certain host defense factors in high concentrations in human milk (1-6). It has been assumed that this protection is mediated by the complex system of immunologic factors in the milk (5, 6) or by interaction of milk factors with agents produced by the infant (7) . Several studies have examined the effect of human milk feeding on the concentration of immune factors in body fluids and excretions of the infant (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . In some studies, the fecal excretion of IgA, lactofenin, and lysozyme was increased in infants fed human milk, a result which suggested that a portion of the ingested factors survived passage through the gastrointestinal tract (8-1 3). However, a maternal origin for the immune factors was not proven in those investigations. Studies of the effects of human milk feeding on immune factors in the saliva and nasal secretions of infants (14-21) have produced conflicting results, perhaps because of variable contamination of the secretions with infants' serum or maternal milk (21) . The effect of human milk feeding on the infant's serum immunoglobulin concentrations also remains controversial (22) (23) (24) (25) .
To investigate the in vivo effects of feeding human milk, we developed a human milk preparation for experimental use in premature infants. It was previously ascertained that this preparation met reasonable microbiologic standards (26) , that the concentrations of many of the immunologic factors in the preparation were maintained after brief high temperature treatment (26) , and that its use resulted in growth rates similar to those observed during intrauterine life (27) . We have also studied its effects on the fecal excretion of selected immunologic factors in VLBW infants (28) . The fecal excretion of human lactoferrin, lysozyme, SIgA, and SIgA antibodies to a pool of Escherichia coli somatic ( 0 ) antigens was greater in infants fed fortified human milk than in those fed a cow's milk formula. No correlation between the ingestion and fecal excretion of individual factors was noted except for SIgA antibodies to E. coli 0 antigens. Although no correlations were noted between the ingested amounts of lactofenin, lysozyme, and SIgA, the excreted amounts of these factors were positively correlated with each other. That observation suggested that unidentified factors in milk may enhance the coordinated production of certain mucosal immune factors by the infant (28) .
To investigate further the possible effects of this human milk preparation on the mucosal immunity of premature infants, we measured the excretion of immunologic factors in the urine of these VLBW infants (27, 28) . Urine was chosen because that external secretion is produced in part by epithelial cells that are not in direct contact with ingested milk, and because it can be collected continuously during test balance periods. The design permitted us to compare the amounts of immunologic factors in the ingested milk with the concentrations of these factors in peripheral blood and the amounts excreted in stool (28) and urine.
MATERIALS AND METHODS
Study design. The study was approved by the institutional review boards of both participating institutions. Two groups of VLBW infants were studied concurrently. One group received only FHM prepared daily by adding heat-treated, lyophilized, mature donor milk to fresh maternal milk (26) (27) (28) . The other group was fed a CMF designed for VLBW infants. The study groups were similar with respect to gestational age (28-30 wk), age at time of balance studies (2.5 wk for the first period; 5 wk for the second period), wt gain, gastrointestinal transit time, total fecal output (27, 28) , and creatinine clearance. Each group received either FHM or CMF exclusively from the time enteral feedings were begun. During the first balance study period, either the FHM or a CMF (Similac PM 60140, Ross Laboratories, Columbus, OH) was fed by continuous nasogastric infusion. During the second period, the infants were fed either the FHM or a CMF formula (Similac 24, Ross Laboratories) by intermittent nasogastric administration. Each subject received the prescribed feedings for at least 1 wk before the balance study. The total vol, caloric, and nitrogen intakes were similar to the two experimental groups (27) . Additional details of the feeding protocol have been described (27, 28) .
During the 96-h balance periods, the infants were placed on a mesh hammock overlying a stainless steel tray arranged for continuous collection of urine. The urine and deionized water rinse drained directly into containers maintained on ice. Unless spills or contamination occurred, individual 12-h urine collections were pooled into four 24-h collections. Human lactofemn, lysozyme, IgA, and SIgA antibodies to E. coli were measured in aliquots of milk and urine, and total SC was measured in urine. At the end of each 96-h collection, a serum sample was obtained to quantify immunoglobulins, lactofemn, and lysozyme.
Immunologic methods. Total IgA and SIgA in milk and total IgA in urine were quantified by immunofluorescence assays using as detectors antihuman a-chain (Bio-Rad Laboratories, Chemical Division, Richmond, CA) and antihuman SC antibodies, respectively (29) . Lactoferrin and lysozyme in milk were measured by electroimmunodiffusion using monospecific antisera (Calbiochem-Behring Corp., La Jolla, CA) (29) . Lactofemn and lysozyme in urine and serum were quantified by ELISA (28) .
Total SC (free SC, SIgA, and SIgM) in urine was measured by a competitive ELISA method using a horseradish peroxidase conjugate of a MAb (3F7) which reacts with similar avidity to fluid phase free SC and SIgA (30) . Conjugated antibody (0.1 ml) diluted 1:4000 in PBS containing Tween-20 (Sigma Chemical Co., St. Louis, MO) and protease inhibitors was mixed with 0.3 ml of urine or purified SIgA standards. Polyethylene glycol 6000 was added to achieve a final concentration of 8.5% (wt/vol), and the mixture was incubated at 4°C overnight. After centrifugation at 400 x g for 20 min, the supernatant was transferred to microtiter plates coated with purified SIgA and incubated for 2 h on ice. Next, the plates were washed, assayed for enzyme activity, and the results expressed as logit of the percentage of antibody conjugate bound. Values for each sample were compared with a standard curve produced from SIgA standards. The sensitivity of the assay was -30 ng/ml, and the response was linear to 4 pg/ml.
Secretory IgA antibodies to a pool of E. coli 0 antigens were quantified by ELISA using antisera to human IgA and SC conjugated to horseradish peroxidase as detectors (29) . Serum levels of IgG, IgA, and IgM were quantified by rate nephelometry (3 1 ).
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The molecular sizes of lactoferrin and SC in urine were examined by Western blotting (32) . Urine samples concentrated 20-to 30-fold by Minicon 10 (Amicon Corp., Danvers, MA) were mixed with equal amounts of the SDS sample buffer and separated by electrophoresis in 7.5% acrylamide gel. The proteins were then transferred electrophoretically from the gel to nitrocellulose sheets. The sheets were blocked with 3% gelatin and then incubated with rabbit antisera to either human lactofemn, IgA, or SC (Dako Corporation, Santa Barbara, CA), washed, and then incubated with goat antisera to rabbit IgG conjugated to horseradish peroxidase (Bio-Rad). After a further wash, the enzyme bound to the sheets was localized by applying chloronaphthol and hydrogen peroxide in methyl alcohol.
The immunologic assays used in this study did not detect any antigens in the cow's milk preparations fed to the VLBW infants.
Data presentation and analysis. The data for immune factors in the milk and urine were not distributed normally. Natural logarithmic transformations of the data were therefore performed for statistical analyses, including repeated measures analysis of variance, Student's t test, and multiple linear regression (33) .
Since multiple comparisons were performed, p values < 0.01 were considered significant. Because there were no differences between results obtained in the first and second balance study periods for either feeding group, the data from both balance periods were combined for presentation. Results are presented as medians, 25th percentiles, and 75th percentiles.
RESULTS

Quantitative urinary excretion of immunologic factors.
The median urinary excretion of lactoferrin, IgA, and total SC in infants fed FHM was increased 7-to 150-fold over that found in CMF-fed infants ( Table 1 ). The quantities of urinary lysozyme were similar in the two groups ( p > 0.5). Secretory IgA antibodies to E. coli 0 antigens were found in the urine of 21% of the infants fed FHM but were not detected in the urine of any infants fed CMF.
Serum concentrations of immunologic factors. There were no differences between the two feeding groups in the concentrations of serum immunoglobulins (including SIgA), lactoferrin, or lysozyme (Table 2) .
Correlation analysis. Significant positive correlations were found in the FHM-fed group between urinary lactoferrin, SC, and IgA, and between IgA in urine and milk. The urinary excretion of these patients was also compared to their fecal excretion in the same infants as reported previously (28) . A correlation was found between urinary SIgA antibodies to E. coli and fecal lactofemn (Table 3) . No other significant correlations were found between quantifications of the ingestion, serum concentration, urinary excretion, or fecal excretion of any of the factors. (Fig. I) . All of the urine samples which demonstrated lactoferrin in this assay had bands which comigrated with the lactoferrin standard (70-80 kD). Lower mol wt forms of lactoferrin that are not present in milk were also detected consistently in these samples. The migration of these principal moieties indicated that their rnol wt were approximately 55%, 49%, 43%, and 39% of the rnol wt of native lactoferrin.
Blots stained with antisera to human SC demonstrated bands which comigrated with standards for free SC and SC covalently linked to polymeric immunoglobulin (SIgA; data not shown). Any SC which was noncovalently associated with immunoglobulins would have been dissociated by the SDS and appeared on the blots as free SC. DISCUSSION Our study demonstrates that the urinary excretion of immunoreactive human lactoferrin, IgA, SC, and SIgA antibodies to E. coli 0 antigens was much greater in VLBW infants fed FHM than in those fed CMF. We considered whether methodologic problems were responsible for those findings. We found no evidence for spillage of FHM or stool into the urine collection, as there were no correlations between the amounts of each factor in milk (28) and urine. To test further whether the urine was contaminated by human milk, we assayed aliquots for a-lactalbumin, a protein unique to human milk and present there in high (mglml) concentrations. Less than half the urine samples from the FHM-fed infants contained detectable a-lactalbumin (>6 ng/ml; data not shown). When the protein was detected, the amount did not correlate with the quantities of the immunologic factors in the urine. If a-lactalbumin is used as a marker for contamination. the maximum extent of contamination of urine samples by milk would be estimated to be less than 1 ppm. This level of contamination could not explain the increased urinary excretion of immune factors. Were the increased levels of immunologic factors in the urine of infants fed FHM derived from ingested milk proteins? This hypothesis was supported by the abundance of these factors in the FHM and their relative resistance to proteolysis by enzymes in the alimentary tract (5). We therefore examined the size of the SC and lactoferrin molecules in the urine from FHM-fed infants. The SC in the urine was present in the free form and bound to IgA dimers. The molecular forms of urinary IgA were not analyzed directly, but the presence of high rnol wt SC on blots and the demonstration of specific SIgA antibodies to E. coli indicate that some intact SIgA was present in the urine of infants fed FHM.
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Although lactoferrin in the milk was only detected as whole molecules, the urine contained intact lactofemn and fragments similar in size to those found in the stools of these same FHMfed infants (data not shown) or produced in vitro by partial tryptic digestion (34) . Since the antilactofemn antiserum used in the ELISA and Western blotting assays reacted with lactoferrin fragments, some of the increase in the lactofemn measured in urine of HMF-fed infants was likely due to these fragments. Further, the similarity in size of the lactofemn fragments in the stool and urine suggests that the VLBW infants fed FHM may absorb lactofemn fragments and excrete them in the urine.
Not all of the differences in the concentration of the immune factors in the urine can be explained by intestinal absorption of immunoreactive fragments, however. Intact lactoferrin, free SC, and SIgA were demonstrated by Western blotting in the urine of FHM-fed but not CMF-fed infants. Serum concentrations of lactoferrin were not increased in infants fed FHM, as one might expect if lactofemn were absorbed from the gastrointestinal tract. Finally, t h e sizes of t h e immune factors in urine, including most of the lactoferrin fragments, were larger than those normally filtered by glomeruli (35, 36) .
We also questioned whether the enhanced excretion of im-munologic proteins might be mediated by specific receptors in the intestinal and urinary tracts. Receptors for human lactofemn have been demonstrated on brush border preparations from rabbit and human intestinal epithelial cells (37, 38) , but they are not thought to mediate absorption of lactoferrin. Binding to these receptors may, however, enhance the absorption of lactoferrin fragments by less specific mechanisms. Secretory component, an epithelial receptor for polymeric IgA, is also present on enterocytes (39) . However, the basolateral localization of SC on enterocytes and lack of SC binding of SIgA, the principal form of IgA in human milk, including milk from mothers of premature infants (40) , argue against SC-mediated intestinal absorption of IgA. Similarly, it seems unlikely that the increased concentration of free SC, demonstrated in the urine of the FHM-fed infants by Western blotting could be attributed to absorption and transport of milk SC, as SC is synthesized as an integral membrane protein and released at the luminal surface of epithelial cells (4 1, 42 ).
An alternate explanation for these results is that feeding human milk enhances the synthesis of immune factors in the infant's urinary tract. Given the lack of correlation between the amounts of different immune factors in milk (28) , the presence of a correlation between the urinary excretion of lactoferrin, total SC, and IgA in infants fed FHM is consistent with coordinated production of urinary immune factors. Induction of synthesis by the infant is a particularly attractive explanation for the presence of intact lactoferrin and free SC in the urine of FHM-fed low birth wt infants.
Recently, Prentice (43) has reported that the breast feeding increases the urinary excretion of IgA 3-fold in 6-and 12-wk-old term infants (43) . The urinary excretion of lactoferrin was not significantly increased in that study. Differences in specimen collection methods make it dificult to compare the quantity of urinary IgA and lactofemn excretion reported (43) to the present study. However, her results indicate that enhancement of urinary excretion of immunologic components by human milk feeding is not restricted to premature infants.
The biologic significance as well as the mechanistic basis of the increased concentration of immune factors in the urine of VLBW infants fed FHM is unclear. Although a direct role for local immune factors in protecting the urinary tract against infection has not been demonstrated, girls with recurrent urinary tract infections have diminished levels of SIgA in their urine when they are not actively infected (44) , and affected women have diminished urinary IgA between and during active infections (45) . Further studies will help to ascertain whether breastfeeding protects against urinary tract infection and whether human milk feeding enhances production or secretion of host defense factors at other mucosal sites.
